In a landmark study (1) published in Transplant International, led by Heidelberg University Hospital in Germany in collaboration with researchers from Sydney, Australia, Proenkephalin A 119-159 (penKid) is identified as a reliable biomarker for the early and precise assessment of graft function trajectories following kidney transplantation.